Cantor Fitzgerald predicts a short-term market rally but warns of bearish trends ahead. Learn more information here.

Protara Therapeutics, Inc. (NASDAQ:TARA – Free Report) – Stock analysts at Cantor Fitzgerald dropped their ... The business’s 50-day moving average price is $4.28 and its 200-day moving ...

Cantor Fitzgerald currently has a “Overweight” rating on the stock. The consensus estimate for Belite Bio’s current full-year earnings is ($1.17) per share. Get Belite Bio alerts ...

Fintel reports that on March 21, 2025, Cantor Fitzgerald initiated coverage of Summit Therapeutics (NasdaqGM:SMMT) with a ...

Meeting to be held in San Francisco on March 31 hosted by Cantor Fitzgerald.Light Up your Portfolio with Spark:Easily identify stocks' risks ...

On Monday, Cantor Fitzgerald reaffirmed its Overweight rating on Rocket Pharmaceuticals (NASDAQ:RCKT) with a steady price target of $50.00. Following a webinar with the company’s management ...

On Tuesday, Cantor Fitzgerald reiterated its Overweight rating on Meta Platforms Inc. (NASDAQ:META) with a price target of $790.00, well above the current trading price of $618.85. The firm’s ...

The coverage initiation by Cantor Fitzgerald is based on the view that Summit’s shares are significantly undervalued by 67%. With analyst targets ranging from $23.63 to $45.02, and a remarkable 447% ...

On Monday, Cantor Fitzgerald analyst Andres Sheppard reaffirmed an Overweight rating with a $10.00 price target on shares of Aurora Innovation Inc (NASDAQ: NASDAQ:AUR), expressing confidence in the ...

The second season of Apple TV+’s “Severance” concluded much like it started — with a harrowing sprint. And for innie Mark, it also ended with a crisis of conscience that led him to make a ...

The last major bear market nearly wiped out the entire crypto-lending industry. Now, it’s staging a major comeback, with a new breed of creditors looking to step into the void and satisfy the ...